Crescent Biopharma (CBIO) files $500M mixed shelf
Tweet
Share
E-mailGet Alerts CBIO Hot Sheet
Price: $16.89 +0.72%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 73.3%
EPS Growth %: +48.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 73.3%
EPS Growth %: +48.0%
Join SI Premium – FREE
Crescent Biopharma (NASDAQ: CBIO) has field $500,000,000 mixed shelf of:
Ordinary Shares
Preferred Shares
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale files for IPO, seeks NYSE listing under ticker NSCL
- Axion Minerals plans flow-through private placement of up to $440K
- First Carolina Financial Services CFO to retire in January 2027
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
